- Home
- MSFT vs AZN Comparison
MSFT vs AZN Comparison
Compare MSFT & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSFT | AZN |
|---|---|---|
| Founded | 1975 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | 96100 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1T | 316.4B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | MSFT | AZN |
|---|---|---|
| Price | $393.65 | $178.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 36 | 1 |
| Target Price | ★ $573.11 | N/A |
| AVG Volume (30 Days) | ★ 27.5M | 1.9M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | 0.86% | ★ 1.73% |
| EPS Growth | ★ 15.59 | N/A |
| EPS | ★ 13.14 | N/A |
| Revenue | ★ $62,484,000,000.00 | N/A |
| Revenue This Year | $18.76 | $10.34 |
| Revenue Next Year | $15.73 | $6.43 |
| P/E Ratio | ★ $30.47 | $31.91 |
| Revenue Growth | ★ 6.93 | N/A |
| 52 Week Low | $356.28 | $68.62 |
| 52 Week High | $555.45 | $212.71 |
Technical Indicators
Market Signals| Indicator | MSFT | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 40.27 | 43.57 |
| Support Level | $393.26 | $174.60 |
| Resistance Level | $426.12 | $191.50 |
| Average True Range (ATR) | 11.48 | 3.13 |
| MACD | -4.40 | -0.18 |
| Stochastic Oscillator | 13.53 | 32.80 |
Price Performance
Historical ComparisonAbout MSFT Microsoft Corporation
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.